Once in a Blue Moon Academia (OBMA)

  Between Cosmetic Grooming, Pharmacology and DHFL Haircut: Ambiguities in the Case of Bohem by Piramal Pharma Limited Posted on 25th October, 2025 (GMT 06:16 hrs) ABSTRACT This paper investigates the regulatory and ethical positioning of Bohem, a men’s grooming product line launched by Piramal Pharma Limited (PPL), within the Indian cosmetic–drug regulatory framework. Drawing upon publicly available documents from the Central Drugs Standard Control Organisation (CDSCO), Piramal Pharma’s corporate communications, and state regulatory norms, the study demonstrates that Bohem—while branded under a major pharmaceutical conglomerate—is not a pharmacologically approved medicine. Rather, it is classified as a cosmetic or personal-care product, subject to the relatively lenient provisions of the Cosmetics Rules 2020. The analysis underscores how blurred categorizations between cosmetics and therapeutics enable large corporations to exploit brand trust associated with pharmaceutical c...

  (W)holistic Resistance and the Courage to Stand Alone: OBMA’s Call for Justice and Dissent in India Posted on 23rd October, 2025 (GMT 09:30 hrs) ABSTRACT This statement reflects OBMA’s introspection and reaffirmation of purpose amid ongoing struggles for justice, accountability, and ecological integrity in India’s increasingly oligarchic and censored environment. Drawing inspiration from Gandhi’s satyagraha, Tagore’s “Ekla Chalo Re,” and the resilience of figures like Umar Khalid, it underscores the moral necessity of walking alone when truth demands it. Acknowledging internal hesitations, systemic suppression, and self-censorship, OBMA calls for renewed ethical persistence, strategic communication, and collective courage — bearing one’s own cross with conscience, foresight, and faith in transformative action. Once in a Blue Moon Academia (OBMA) announces the closure of its WhatsApp and Telegram channels within the next 24 hours — not as a retreat, but as a strategic pause t...